Zimmer Biomet

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products.

CEO

Ivan Tornos

CEOIvan Tornos

Employees

17,000

Employees17,000

Headquarters

Warsaw, Indiana

HeadquartersWarsaw, Indiana

Founded

1927

Founded1927

Employees

17,000

Employees17,000

ZBH Key Statistics

Market cap

16.06B

Market cap16.06B

Price-Earnings ratio

21.55

Price-Earnings ratio21.55

Dividend yield

1.16%

Dividend yield1.16%

Average volume

3.42M

Average volume3.42M

High today

$83.68

High today$83.68

Low today

$82.14

Low today$82.14

Open price

$83.08

Open price$83.08

Volume

1.61M

Volume1.61M

52 Week high

$108.29

52 Week high$108.29

52 Week low

$79.83

52 Week low$79.83

Stock Snapshot

The current Zimmer Biomet(ZBH) stock price is $82.50, with a market capitalization of 16.06B. The stock trades at a price-to-earnings (P/E) ratio of 21.55 and offers a dividend yield of 1.2%.

On 2026-05-06, Zimmer Biomet(ZBH) stock moved within a range of $82.14 to $83.68. With shares now at $82.50, the stock is trading +0.4% above its intraday low and -1.4% below the session's peak.

Trading activity shows a volume of 1.61M, compared to an average daily volume of 3.42M.

The stock's 52-week range extends from a low of $79.83 to a high of $108.29.

ZBH News

Simply Wall St 3d

Zimmer Biomet Is Down 9.2% After Strong Q1, CFO Exit And Ongoing Buybacks – Has The Bull Case Changed?

In late April 2026, Zimmer Biomet Holdings reported first-quarter 2026 results showing sales of US$2,086.7 million and net income of US$238.1 million, reaffirme...

Simply Wall St 6d

Zimmer Biomet Valuation Check After Strong Q1 Earnings And Abrupt CFO Resignation

Zimmer Biomet Holdings (ZBH) drew attention after first quarter 2026 earnings showed higher sales and net income year on year, while the immediate resignation o...

TipRanks 7d

Zimmer Biomet price target lowered to $92 from $98 at Truist

Truist lowered the firm’s price target on Zimmer Biomet (ZBH) to $92 from $98 and keeps a Hold rating on the shares. The company delivered 2.9% organic revenue...

Analyst ratings

61%

of 31 ratings

Buy

29%

Hold

61.3%

Sell

9.7%

More ZBH News

Benzinga 7d

These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported upbeat earnings for the first quarter on Tuesday. The company posted first-quarter adjusted earnings of $2.09...

TipRanks 7d

Zimmer Biomet: Hold Reiterated as Execution Risks, Salesforce Transition, and CFO Departure Offset Q1 Beat and Margin Upside

William Blair analyst Steven Lichtman has maintained their neutral stance on ZBH stock, giving a Hold rating today. Claim 55% Off TipRanks Unlock hedge fund-lev...

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.